Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thomas Joseph Brady, M.D.

Co-Author

This page shows the publications co-authored by Thomas Brady and Ralph Weissleder.
Connection Strength

1.505
  1. MR lymphography: study of a high-efficiency lymphotrophic agent. Radiology. 1994 Apr; 191(1):225-30.
    View in: PubMed
    Score: 0.148
  2. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology. 1992 Feb; 182(2):381-5.
    View in: PubMed
    Score: 0.127
  3. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. Radiology. 1991 Oct; 181(1):245-9.
    View in: PubMed
    Score: 0.124
  4. MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. AJR Am J Roentgenol. 1990 Dec; 155(6):1161-7.
    View in: PubMed
    Score: 0.117
  5. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology. 1990 May; 175(2):494-8.
    View in: PubMed
    Score: 0.113
  6. Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging. AJR Am J Roentgenol. 1998 Jul; 171(1):137-43.
    View in: PubMed
    Score: 0.050
  7. Magnetically labeled secretin retains receptor affinity to pancreas acinar cells. Bioconjug Chem. 1996 May-Jun; 7(3):311-6.
    View in: PubMed
    Score: 0.043
  8. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties. Bioconjug Chem. 1996 Jan-Feb; 7(1):144-9.
    View in: PubMed
    Score: 0.042
  9. Experimental gastrointestinal hemorrhage: detection with contrast-enhanced MR imaging and scintigraphy. Radiology. 1995 Jul; 196(1):239-44.
    View in: PubMed
    Score: 0.040
  10. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM. Magn Reson Med. 1995 Jan; 33(1):88-92.
    View in: PubMed
    Score: 0.039
  11. Synthetic copolymer kit for radionuclide blood-pool imaging. J Nucl Med. 1994 Nov; 35(11):1880-6.
    View in: PubMed
    Score: 0.039
  12. Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging. Radiology. 1994 Nov; 193(2):527-31.
    View in: PubMed
    Score: 0.039
  13. Determinants of in vivo MR imaging of slow axonal transport. Radiology. 1994 Nov; 193(2):485-91.
    View in: PubMed
    Score: 0.039
  14. Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. Biochim Biophys Acta. 1994 Jul 13; 1193(1):212-8.
    View in: PubMed
    Score: 0.038
  15. Dynamic gadolinium-enhanced echo-planar MR imaging of the liver: effect of pulse sequence and dose on enhancement. J Magn Reson Imaging. 1994 May-Jun; 4(3):331-5.
    View in: PubMed
    Score: 0.037
  16. Detection of pulmonary emboli by using MR angiography with MPEG-PL-GdDTPA: an experimental study in rabbits. AJR Am J Roentgenol. 1994 May; 162(5):1041-6.
    View in: PubMed
    Score: 0.037
  17. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. AJR Am J Roentgenol. 1994 Jan; 162(1):209-13.
    View in: PubMed
    Score: 0.036
  18. AUR Memorial Award 1993. A drug system (PDH) for interventional radiology. Synthesis, properties, and efficacy. Invest Radiol. 1993 Dec; 28(12):1083-9.
    View in: PubMed
    Score: 0.036
  19. MR imaging of slow axonal transport in vivo. Exp Neurol. 1993 Oct; 123(2):235-42.
    View in: PubMed
    Score: 0.036
  20. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology. 1993 Jun; 187(3):701-6.
    View in: PubMed
    Score: 0.035
  21. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med. 1993 May; 29(5):599-604.
    View in: PubMed
    Score: 0.035
  22. Polymeric contrast agents for MR imaging of adrenal glands. J Magn Reson Imaging. 1993 Jan-Feb; 3(1):93-7.
    View in: PubMed
    Score: 0.034
  23. MION-ASF: biokinetics of an MR receptor agent. Magn Reson Imaging. 1993; 11(3):411-7.
    View in: PubMed
    Score: 0.034
  24. Animal models for magnetic resonance imaging research of the liver. Invest Radiol. 1992 May; 27(5):390-3.
    View in: PubMed
    Score: 0.032
  25. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents. J Magn Reson Imaging. 1992 Mar-Apr; 2(2):177-81.
    View in: PubMed
    Score: 0.032
  26. Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assays. Radiology. 1992 Feb; 182(2):565-9.
    View in: PubMed
    Score: 0.032
  27. Asialoglycoprotein receptor function in benign liver disease: evaluation with MR imaging. Radiology. 1991 Mar; 178(3):769-74.
    View in: PubMed
    Score: 0.030
  28. Receptor imaging: application to MR imaging of liver cancer. Radiology. 1990 Dec; 177(3):729-34.
    View in: PubMed
    Score: 0.029
  29. Cerebral iron oxide distribution: in vivo mapping with MR imaging. Radiology. 1995 Aug; 196(2):521-7.
    View in: PubMed
    Score: 0.010
  30. Experimental hepatocellular carcinoma: MR receptor imaging. Radiology. 1991 Sep; 180(3):641-5.
    View in: PubMed
    Score: 0.008
  31. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology. 1991 May; 179(2):529-33.
    View in: PubMed
    Score: 0.008
  32. Lymph nodes: microstructural anatomy at MR imaging. Radiology. 1991 Feb; 178(2):519-22.
    View in: PubMed
    Score: 0.007
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.